Kurome Therapeutics

0 followers


Kurome Therapeutics is developing therapies that target cancer cells that have co-opted immune signaling pathways in order to avoid destruction by traditional therapeutic agents and subvert adaptive resistance mechanisms.

Industries

Headquarters

Stage

Employees

Links

Org chart

Jan Rosenbaum
President & CEO

Jan Rosenbaum

Collapse
Paul Gaitan
Interim CFO
Mehdi Shahidi
Interim CMO
Gregory Hayes
Vice President, Translational Medicine
Brandi Soldo
VP, Pharmacology & Toxicology
Amal Kolt
Lab Manager